Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of satralizumab in facioscapulohumeral muscular dystrophy type 1. The trial is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facioscapulohumeral Muscular Dystrophy Type

Drugs mentioned

• Satralizumab (satralizumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Facioscapulohumeral Muscular Dystrophy 1 | Phase 2 | Status: ACTIVE_NOT_RECRUITING